Macek Jilkova, Z.; Aspord, C.; Decaens, T.
Reply to Comment on “Jilkova, Z.M.; et al. Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges” Cancers 2019, 11, 1554. Cancers 2020, 12, 2673.
https://doi.org/10.3390/cancers12092673
AMA Style
Macek Jilkova Z, Aspord C, Decaens T.
Reply to Comment on “Jilkova, Z.M.; et al. Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges” Cancers 2019, 11, 1554. Cancers. 2020; 12(9):2673.
https://doi.org/10.3390/cancers12092673
Chicago/Turabian Style
Macek Jilkova, Zuzana, Caroline Aspord, and Thomas Decaens.
2020. "Reply to Comment on “Jilkova, Z.M.; et al. Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges” Cancers 2019, 11, 1554" Cancers 12, no. 9: 2673.
https://doi.org/10.3390/cancers12092673
APA Style
Macek Jilkova, Z., Aspord, C., & Decaens, T.
(2020). Reply to Comment on “Jilkova, Z.M.; et al. Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges” Cancers 2019, 11, 1554. Cancers, 12(9), 2673.
https://doi.org/10.3390/cancers12092673